Cite
Torres S, Brol MJ, Magdaleno F, et al. The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis. Front Mol Biosci. 2021;8:715765doi: 10.3389/fmolb.2021.715765.
Torres, S., Brol, M. J., Magdaleno, F., Schierwagen, R., Uschner, F. E., Klein, S., Ortiz, C., Tyc, O., Bachtler, N., Stunden, J., Bertheloot, D., Kitanovic, A., Sanchez, B., Schrum, J., Roush, W. R., Franchi, L., Byth, K., Latz, E., & Trebicka, J. (2021). The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis. Frontiers in molecular biosciences, 8715765. https://doi.org/10.3389/fmolb.2021.715765
Torres, Sandra, et al. "The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis." Frontiers in molecular biosciences vol. 8 (2021): 715765. doi: https://doi.org/10.3389/fmolb.2021.715765
Torres S, Brol MJ, Magdaleno F, Schierwagen R, Uschner FE, Klein S, Ortiz C, Tyc O, Bachtler N, Stunden J, Bertheloot D, Kitanovic A, Sanchez B, Schrum J, Roush WR, Franchi L, Byth K, Latz E, Trebicka J. The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis. Front Mol Biosci. 2021 Aug 13;8:715765. doi: 10.3389/fmolb.2021.715765. eCollection 2021. PMID: 34513923; PMCID: PMC8425476.
Copy
Download .nbib